A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials-Reference-Cited by-同舟云学术

A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials

Author:

Dorris Kathleen¹,Liu Chunyan²,Li Dandan³,Hummel Trent R.⁴,Wang Xia⁵,Perentesis John⁴,Kim Mi-Ok⁶,Fouladi Maryam⁴

Affiliation:

1. Section of Pediatric Hematology, Oncology, Bone Marrow Transplantation; Children's Hospital Colorado; Aurora Colorado

2. Division of Biostatistics and Epidemiology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

3. Consumer Credit Risk Management; Fifth Third Bank; Cincinnati Ohio

4. Division of Oncology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

5. Department of Mathematical Sciences; University of Cincinnati; Cincinnati Ohio

6. Department of Epidemiology and Biostatistics; University of California San Francisco

Funder

Agency for Healthcare Research and Quality

Ruth L. Kirschstein National Research Service Award

National Institute of Environmental Health Sciences

Paul Calabresi Career Development Award for Clinical Oncology

National Cancer Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference159 articles.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献